Tech Company Financing Transactions
Connecta Therapeutics Funding Round
Connecta Therapeutics, based in Barcelona, raised $3.5 million in funding from Clave, CDTI and Inveready Technology Investment Group.
Transaction Overview
Company Name
Announced On
9/10/2026
Transaction Type
Venture Equity
Amount
$3,500,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to expand operation and its development efforts.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Baldiri Reixac, 10-12
Barcelona, 08028
Spain
Barcelona, 08028
Spain
Phone
Undisclosed
Website
Email Address
Overview
CONNECTA Therapeutics S.L. is a clinical-stage biotech company pioneering first-in-class neuroplasticity modulators to address unmet CNS medical needs in central nervous system (CNS) disorders. At CONNECTA, we are leveraging our small-molecule neuroplasticity modulation platform with a focus on paediatric neurodevelopmental conditions. Neuroplasticity is the ability of the nervous system to adapt its activity in response to intrinsic or extrinsic stimuli by reorganizing its structure, functions, and connections, and is impaired in the vast majority of these disorders.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jordi Fàbrega
Co-Founder
Josep Prous
Browse more venture capital transactions:
Prev: 9/10/2026: Clay Labs venture capital transaction
Next: 9/10/2026: Tavion venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs